𝔖 Bobbio Scriptorium
✦   LIBER   ✦

RIP2 polymorphisms in inflammatory bowel diseases

✍ Scribed by R. Thiébaut; V. Douchin; C. Jung; F. Merlin; J.F. Colombel; M. Lemann; S. Almer; C. Tysk; C. O'Morain; M. Gassull; Y. Finkel; H. Zouali; L. Pascoe; J.P. Hugot

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
40 KB
Volume
17
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lymphoma in inflammatory bowel disease
Lymphoma in inflammatory bowel disease
✍ Adrian J. Greenstein; Gerard E. Mullin; James A. Strauchen; Tomas Heimann; Henry 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 481 KB 👁 1 views
MicroRNAs in inflammatory bowel disease
MicroRNAs in inflammatory bowel disease
✍ Joel R. Pekow; John H. Kwon 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

MicroRNAs (miRNAs) are small, noncoding RNAs that regulate gene and protein expression. miRNAs are critical to a normal immune response and have altered expression in multiple immune-mediated disorders. This emerging role of miRNAs in the pathogenesis of multiple disease states has led to investigat

Intestinal barrier dysfunction in inflam
Intestinal barrier dysfunction in inflammatory bowel diseases
✍ Michael A. McGuckin; Rajaraman Eri; Lisa A. Simms; Timothy H.J. Florin; Graham R 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB

The etiology of human inflammatory bowel diseases (IBDs) is believed to involve inappropriate host responses to the complex commensal microbial flora in the gut, although an altered commensal flora is not completely excluded. A multifunctional cellular and secreted barrier separates the microbial fl

Cerebral venous thrombosis in inflammato
Cerebral venous thrombosis in inflammatory bowel diseases
✍ Sébastien Richard; Aurélia Fairise; Jean-Christophe Lacour; Xavier Ducrocq 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB

Thromboembolic disease is a rare but serious complication of inflammatory bowel diseases (IBD) such as Crohn's disease (CD) and ulcerative colitis (UC). Talbot et al 1 found only 1.3% of thromboembolic complications in a population of 7199 patients with IBD during an 11-year period. Prognosis is poo